As weight loss medications containing active ingredients like semaglutide continue to define a new chapter in metabolic ...

Wegovy is a medication typically prescribed for weight loss and cardiovascular risk reduction individuals with overweight or ...

Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in ...

A combination of human and artificial intelligence has paved the way for a GLP-1 agonist that is effective when taken by mouth. Not only does it have a tongue-twisting name, “orforglipron” has a ...

Starting July 1, about 14 million people on Medicare who have been diagnosed as obese or overweight will be eligible for $50 ...

Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs A new weight-loss drug has helped participants in a sizable trial lose much more ...

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news ...

What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss. By Mark Miller Millions of older Americans may have access for the first time to obesity drugs ...

WeightWatchers' Core+ program offers personalized weight loss support starting at $20 per month. The program focuses on nutrition, habit-building and community support. Core+ features specialized ...

The Trump administration's promised Medicare pilot program for GLP-1 weight-lossdrugs was positioned to help cover the costs of these medications, helpingseniors avoidwasting money in retirement while ...